CTOR

Citius Oncology
CTOR

Overview Fund Trends Analyst Outlook Journalist POV

24 hedge funds and large institutions have $54.1M invested in Citius Oncology in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $
Holders
24
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.04M
2
+$3.36M
3
+$3.3M
4
RCM
Radcliffe Capital Management
Pennsylvania
+$2.55M
5
SCM
Shaolin Capital Management
Florida
+$2.07M

Top Sellers

1
-$1.52M
2
-$77.3K
3
-$36.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$6.04M
2
$6.02M
3
$5.2M
4
$4.26M
5
$4.14M
6
$3.64M
7
$3.36M
8
$3.12M
9
$3.07M
10
$2.59M
11
$2.55M
12
$1.88M
13
$1.55M
14
$1.4M
15
$1.3M
16
$1.26M
17
$1.08M
18
$777K
19
$406K
20
$188K
21
$131K
22
$108K
23
$15.6K
24
$662
25
–